Company

Solarea Bio, Inc.

Solarea Bio develops natural products for age-related inflammatory conditions using Microscape Technology.

About

Founded in 2017 and based in Cambridge, US, Solarea Bio develops products using its Microscape Technology™, which isolates beneficial bacteria and fungi found in fruits and vegetables. Its formulations target conditions including rheumatoid arthritis, psoriatic arthritis and cellular aging. In May 2023, it raised USD 15.00 mn in Series B funding from S2G Ventures, Bold Capital Partners, GG 1978 SICAF SIF S.A. and Viking Global Investors.

3Funding rounds

4Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in